4.2005.00% ( +0.200 )
Delay Closed: Nov 16, 16:08:00Profile
About

YZYBIO-B
02496.HK
Wuhan YZY Biopharma Co., Ltd., a biotechnology company, develops bispecific antibody-based therapies for the treatment of cancer, cancer-associated complications, and age-related ophthalmologic diseases. It develops various product candidates for the treatment of malignant ascites, malignant pleural effusion, solid tumors, pancreatic cancer, hepatocellular carcinoma, and other advanced solid tumors; wAMD, DME, and other ocular neovascularization-related diseases; hemophilia; and inflammatory bowel diseases. The company was founded in 2010 and is headquartered in Wuhan, China.
Profile
- Company Name
- Wuhan YZY Biopharma Co., Ltd.
- Market
- SEHK
- Founded
- Industry
- --
- Fiscal Year End
- December 31
- Website
- www.yzybio.com
Related Securities
Industry
Industry RankingsValueRank
Management
NamePosition
